Cargando…
Effects of the COVID-19 Pandemic on Pharmacovigilance Strategy, Systems, and Processes of Large, Medium, and Small Companies: An Industry Survey
PURPOSE: The COVID-19 pandemic poses an unprecedented threat to global business relationships and dynamics. The pharmacovigilance function of pharmaceutical companies is particularly susceptible to changing external pressures because of its highly structured compliance activities. We conducted an in...
Autores principales: | Beninger, Paul, Caubel, Patrick, Sharma, Latika, Pajovich, Geo, Boyd, Pete |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309098/ https://www.ncbi.nlm.nih.gov/pubmed/35940940 http://dx.doi.org/10.1016/j.clinthera.2022.07.007 |
Ejemplares similares
-
Influence of COVID-19 on the Pharmacovigilance Workforce of the Future
por: Beninger, Paul
Publicado: (2021) -
Pharmacovigilance in pharmaceutical companies: An overview
por: Mammì, Maria, et al.
Publicado: (2013) -
Good Pharmacovigilance Practice: Accountability of Ayurvedic Pharmaceutical Companies
por: Sharma, Rohit, et al.
Publicado: (2017) -
Pharmacovigilance obligations of the pharmaceutical companies in India
por: Arora, Deepa
Publicado: (2008) -
Response to "Pharmacovigilance 2030: Invited Commentary for the January 2020 ‘Futures’ Edition"
por: Hauben, Manfred, et al.
Publicado: (2020)